Pretty significant news, all of a sudden there are potential multiple revenue streams from lymphedema, heart and renal. Could be a cash cow in 2022.... current MC pretty cheap given the potential, I just hope we don't get taken over beforehand because the hawks must be circling.
Ann: FDA Grants Breakthrough Device Designation for Renal Failure, page-4
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
-0.003(4.48%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 6.5¢ | 6.8¢ | 6.3¢ | $106.5K | 1.635M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103932 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| IPD (ASX) Chart |